55 related articles for article (PubMed ID: 22824147)
41. Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype.
Ciereszko A; Dietrich MA; Słowińska M; Nynca J; Ciborowski M; Kaczmarek MM; Myszczyński K; Kiśluk J; Majewska A; Michalska-Falkowska A; Kodzik N; Reszeć J; Sierko E; Nikliński J
PLoS One; 2022; 17(5):e0268073. PubMed ID: 35512017
[TBL] [Abstract][Full Text] [Related]
42. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.
Li QK; Shah P; Li Y; Aiyetan PO; Chen J; Yung R; Molena D; Gabrielson E; Askin F; Chan DW; Zhang H
J Proteome Res; 2013 Aug; 12(8):3689-96. PubMed ID: 23802180
[TBL] [Abstract][Full Text] [Related]
43. Expression of cathepsin D in transitional cell bladder tumours.
Lipponen PK
J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
[TBL] [Abstract][Full Text] [Related]
45. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
Okayama H; Kohno T; Ishii Y; Shimada Y; Shiraishi K; Iwakawa R; Furuta K; Tsuta K; Shibata T; Yamamoto S; Watanabe S; Sakamoto H; Kumamoto K; Takenoshita S; Gotoh N; Mizuno H; Sarai A; Kawano S; Yamaguchi R; Miyano S; Yokota J
Cancer Res; 2012 Jan; 72(1):100-11. PubMed ID: 22080568
[TBL] [Abstract][Full Text] [Related]
46. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
[TBL] [Abstract][Full Text] [Related]
47. Toward personalized medicine of lung cancer: response to nontargeted therapy in invasive pulmonary adenocarcinoma as a function of tumor cell differentiation.
Hartel PH; Hartel JV; Fanburg-Smith JC; Gilmore RW; Fleming D; Barnett S; Mudry R; Parker JE
Int J Surg Pathol; 2013 Jun; 21(3):224-8. PubMed ID: 23637254
[TBL] [Abstract][Full Text] [Related]
48. Cathepsin D as a potential prognostic marker for lung adenocarcinoma.
Mimae T; Tsuta K; Maeshima AM; Okada M; Asamura H; Kondo T; Tsuda H
Pathol Res Pract; 2012 Sep; 208(9):534-40. PubMed ID: 22824147
[TBL] [Abstract][Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
